# One-year efficacy of adjunctive use of Ripasudil, a rho-kinase inhibitor, in patients with glaucoma inadequately controlled with maximum medical therapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/one-year-efficacy-of-adjunctive-use-of-ripasudil-a-rho-kinase-inhibitor-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hiroshi Inazaki,Satoshi Kobayashi,Yoko Anzai,Hisayoshi Satoh,Shimpei Sato,Maiko Inoue,Shin Yamane,Kazuaki Kadonosono |
| Citations | 31 |
| DOI | 10.1007/s00417-017-3727-5 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2734542162 |
| PMID | 28711991 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Satoshi Kobayashi](https://scholariq.org/researchers/satoshi-kobayashi/)

## Paper journal

- [Graefe s Archive for Clinical and Experimental Ophthalmology](https://scholariq.org/journals/graefe-s-archive-for-clinical-and-experimental-ophthalmology/)

## Paper primary topic

- [Glaucoma and retinal disorders](https://scholariq.org/topics/glaucoma-and-retinal-disorders/)

## Paper topics

- [Glaucoma and retinal disorders](https://scholariq.org/topics/glaucoma-and-retinal-disorders/)
- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)
- [Corneal surgery and disorders](https://scholariq.org/topics/corneal-surgery-and-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.